Logo image of LXS.DE

LANXESS AG (LXS.DE) Stock Fundamental Analysis

FRA:LXS - Deutsche Boerse Ag - DE0005470405 - Common Stock - Currency: EUR

31.97  -0.99 (-3%)

Fundamental Rating

4

Overall LXS gets a fundamental rating of 4 out of 10. We evaluated LXS against 61 industry peers in the Chemicals industry. Both the profitability and financial health of LXS have multiple concerns. LXS has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

LXS had positive earnings in the past year.
In the past year LXS had a positive cash flow from operations.
Each year in the past 5 years LXS has been profitable.
In the past 5 years LXS always reported a positive cash flow from operatings.
LXS.DE Yearly Net Income VS EBIT VS OCF VS FCFLXS.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M -200M 400M 600M 800M

1.2 Ratios

LXS's Return On Assets of -9.16% is on the low side compared to the rest of the industry. LXS is outperformed by 71.43% of its industry peers.
The Return On Equity of LXS (-19.78%) is worse than 71.43% of its industry peers.
Industry RankSector Rank
ROA -9.16%
ROE -19.78%
ROIC N/A
ROA(3y)3.11%
ROA(5y)4.33%
ROE(3y)7.54%
ROE(5y)11.96%
ROIC(3y)N/A
ROIC(5y)N/A
LXS.DE Yearly ROA, ROE, ROICLXS.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 5 10 15 20 25

1.3 Margins

LXS's Profit Margin has been stable in the last couple of years.
In the last couple of years the Operating Margin of LXS has grown nicely.
With a Gross Margin value of 19.39%, LXS is not doing good in the industry: 65.08% of the companies in the same industry are doing better.
LXS's Gross Margin has declined in the last couple of years.
LXS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 19.39%
OM growth 3Y12.58%
OM growth 5Y1.67%
PM growth 3Y-23.02%
PM growth 5Y0.92%
GM growth 3Y-9.51%
GM growth 5Y-5.81%
LXS.DE Yearly Profit, Operating, Gross MarginsLXS.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 5 10 15 20 25

More info and screens

3

2. Health

2.1 Basic Checks

LXS does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, LXS has about the same amount of shares outstanding.
LXS has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, LXS has an improved debt to assets ratio.
LXS.DE Yearly Shares OutstandingLXS.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M
LXS.DE Yearly Total Debt VS Total AssetsLXS.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B 8B 10B

2.2 Solvency

Based on the Altman-Z score of 1.68, we must say that LXS is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of LXS (1.68) is worse than 63.49% of its industry peers.
LXS has a debt to FCF ratio of 42.44. This is a negative value and a sign of low solvency as LXS would need 42.44 years to pay back of all of its debts.
LXS has a Debt to FCF ratio (42.44) which is comparable to the rest of the industry.
LXS has a Debt/Equity ratio of 0.56. This is a neutral value indicating LXS is somewhat dependend on debt financing.
The Debt to Equity ratio of LXS (0.56) is worse than 60.32% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.56
Debt/FCF 42.44
Altman-Z 1.68
ROIC/WACCN/A
WACC4.94%
LXS.DE Yearly LT Debt VS Equity VS FCFLXS.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1B 2B 3B 4B

2.3 Liquidity

A Current Ratio of 1.96 indicates that LXS should not have too much problems paying its short term obligations.
The Current ratio of LXS (1.96) is better than 66.67% of its industry peers.
LXS has a Quick Ratio of 1.17. This is a normal value and indicates that LXS is financially healthy and should not expect problems in meeting its short term obligations.
LXS has a Quick ratio (1.17) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.96
Quick Ratio 1.17
LXS.DE Yearly Current Assets VS Current LiabilitesLXS.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 1B 2B 3B 4B 5B

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 281.36% over the past year.
The Earnings Per Share has been growing slightly by 1.81% on average over the past years.
LXS shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -12.85%.
The Revenue has been decreasing by -0.32% on average over the past years.
EPS 1Y (TTM)281.36%
EPS 3Y-20.47%
EPS 5Y1.81%
EPS Q2Q%156.58%
Revenue 1Y (TTM)-12.85%
Revenue growth 3Y3.23%
Revenue growth 5Y-0.32%
Sales Q2Q%-0.19%

3.2 Future

LXS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 35.98% yearly.
LXS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 0.32% yearly.
EPS Next Y160.46%
EPS Next 2Y77.87%
EPS Next 3Y54.04%
EPS Next 5Y35.98%
Revenue Next Year-6.58%
Revenue Next 2Y-2.31%
Revenue Next 3Y-0.3%
Revenue Next 5Y0.32%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
LXS.DE Yearly Revenue VS EstimatesLXS.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2B 4B 6B 8B
LXS.DE Yearly EPS VS EstimatesLXS.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 2 4

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 29.88, which means the current valuation is very expensive for LXS.
LXS's Price/Earnings ratio is in line with the industry average.
LXS's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 29.35.
A Price/Forward Earnings ratio of 20.20 indicates a rather expensive valuation of LXS.
The rest of the industry has a similar Price/Forward Earnings ratio as LXS.
The average S&P500 Price/Forward Earnings ratio is at 22.10. LXS is around the same levels.
Industry RankSector Rank
PE 29.88
Fwd PE 20.2
LXS.DE Price Earnings VS Forward Price EarningsLXS.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

LXS's Enterprise Value to EBITDA is on the same level as the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of LXS is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 38.88
EV/EBITDA 12.01
LXS.DE Per share dataLXS.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
LXS's earnings are expected to grow with 54.04% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.19
PEG (5Y)16.54
EPS Next 2Y77.87%
EPS Next 3Y54.04%

More info and screens

2

5. Dividend

5.1 Amount

With a yearly dividend of 0.30%, LXS is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 2.89, LXS is paying slightly less dividend.
Compared to an average S&P500 Dividend Yield of 2.33, LXS's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.3%

5.2 History

The dividend of LXS has a limited annual growth rate of 5.44%.
Dividend Growth(5Y)5.44%
Div Incr Years0
Div Non Decr Years4
LXS.DE Yearly Dividends per shareLXS.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

LXS has negative earnings and hence a negative payout ratio. The dividend may be in danger.
LXS's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP-1.04%
EPS Next 2Y77.87%
EPS Next 3Y54.04%
LXS.DE Yearly Income VS Free CF VS DividendLXS.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M -200M 400M 600M 800M

More info and screens

LANXESS AG

FRA:LXS (3/7/2025, 7:00:00 PM)

31.97

-0.99 (-3%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)11-07 2024-11-07/bmo
Earnings (Next)03-20 2025-03-20/amc
Inst Owners64.41%
Inst Owner ChangeN/A
Ins Owners2.86%
Ins Owner ChangeN/A
Market Cap2.76B
Analysts71.43
Price Target29.8 (-6.79%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.3%
Yearly Dividend1.05
Dividend Growth(5Y)5.44%
DP-1.04%
Div Incr Years0
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)301%
Min EPS beat(2)130.13%
Max EPS beat(2)471.87%
EPS beat(4)4
Avg EPS beat(4)188.73%
Min EPS beat(4)62.99%
Max EPS beat(4)471.87%
EPS beat(8)7
Avg EPS beat(8)107.04%
EPS beat(12)10
Avg EPS beat(12)75.94%
EPS beat(16)14
Avg EPS beat(16)60.78%
Revenue beat(2)0
Avg Revenue beat(2)-3.49%
Min Revenue beat(2)-4.37%
Max Revenue beat(2)-2.61%
Revenue beat(4)1
Avg Revenue beat(4)-4.13%
Min Revenue beat(4)-10.36%
Max Revenue beat(4)0.82%
Revenue beat(8)2
Avg Revenue beat(8)-3.22%
Revenue beat(12)3
Avg Revenue beat(12)-4.83%
Revenue beat(16)3
Avg Revenue beat(16)-5.66%
PT rev (1m)-0.19%
PT rev (3m)-0.65%
EPS NQ rev (1m)0%
EPS NQ rev (3m)11.9%
EPS NY rev (1m)-7.08%
EPS NY rev (3m)13.46%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.19%
Revenue NY rev (1m)0.14%
Revenue NY rev (3m)-1.3%
Valuation
Industry RankSector Rank
PE 29.88
Fwd PE 20.2
P/S 0.44
P/FCF 38.88
P/OCF 7.32
P/B 0.63
P/tB 1.41
EV/EBITDA 12.01
EPS(TTM)1.07
EY3.35%
EPS(NY)1.58
Fwd EY4.95%
FCF(TTM)0.82
FCFY2.57%
OCF(TTM)4.37
OCFY13.66%
SpS73.18
BVpS50.63
TBVpS22.61
PEG (NY)0.19
PEG (5Y)16.54
Profitability
Industry RankSector Rank
ROA -9.16%
ROE -19.78%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 19.39%
FCFM 1.12%
ROA(3y)3.11%
ROA(5y)4.33%
ROE(3y)7.54%
ROE(5y)11.96%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)5.37%
ROCE(5y)5.88%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y12.58%
OM growth 5Y1.67%
PM growth 3Y-23.02%
PM growth 5Y0.92%
GM growth 3Y-9.51%
GM growth 5Y-5.81%
F-Score3
Asset Turnover0.67
Health
Industry RankSector Rank
Debt/Equity 0.56
Debt/FCF 42.44
Debt/EBITDA 5.95
Cap/Depr 30.78%
Cap/Sales 4.84%
Interest Coverage N/A
Cash Conversion 92.4%
Profit Quality N/A
Current Ratio 1.96
Quick Ratio 1.17
Altman-Z 1.68
F-Score3
WACC4.94%
ROIC/WACCN/A
Cap/Depr(3y)66.88%
Cap/Depr(5y)78.42%
Cap/Sales(3y)5.91%
Cap/Sales(5y)6.54%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)281.36%
EPS 3Y-20.47%
EPS 5Y1.81%
EPS Q2Q%156.58%
EPS Next Y160.46%
EPS Next 2Y77.87%
EPS Next 3Y54.04%
EPS Next 5Y35.98%
Revenue 1Y (TTM)-12.85%
Revenue growth 3Y3.23%
Revenue growth 5Y-0.32%
Sales Q2Q%-0.19%
Revenue Next Year-6.58%
Revenue Next 2Y-2.31%
Revenue Next 3Y-0.3%
Revenue Next 5Y0.32%
EBIT growth 1Y-606.02%
EBIT growth 3Y16.22%
EBIT growth 5Y1.34%
EBIT Next Year1510.71%
EBIT Next 3Y176.94%
EBIT Next 5Y87.5%
FCF growth 1Y144.1%
FCF growth 3Y58.33%
FCF growth 5Y41.9%
OCF growth 1Y27.36%
OCF growth 3Y12.73%
OCF growth 5Y7.42%